Docetaxel, Doxorubicin, and Cyclophosphamide in Treating Women With Advanced Breast Cancer
Status:
Withdrawn
Trial end date:
2003-12-01
Target enrollment:
Participant gender:
Summary
RATIONALE: Drugs used in chemotherapy, such as docetaxel, doxorubicin, and cyclophosphamide,
use different ways to stop tumor cells from dividing so they stop growing or die. Combining
more than one drug and giving them at different times, may kill more tumor cells. It is not
yet known which combination chemotherapy regimen is more effective for breast cancer.
PURPOSE: Randomized phase I trial to compare the effectiveness of two regimens of docetaxel
combined with doxorubicin and cyclophosphamide in treating women who have advanced breast
cancer.